Skip to Main Content

Paper Details

Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapy.
J Am Acad Dermatol
31
2015
BRAF, BRAF-mutant metastatic melanoma, BRAFi, BRAFi cuSCC, MAPK, cuSCC, cutaneous squamous cell carcinoma, keratinocytes, melanoma, patients, sporadic cuSCC
Author NameAffiliation
Karen BythWestmead Hospital
Karen BythWestmead Hospital
Raghwa SharmaWestmead Hospital, Australia Sydney Medical School, University of Sydney, University of Western Sydney
Richard A ScolyerSydney Medical School, University of Sydney, Australia Melanoma Institute Australia, Royal Prince Alfred Hospital
Georgina V LongWestmead Institute for Cancer Research, Westmead Hospital, Australia Sydney Medical School, University of Sydney, Australia Melanoma Institute Australia
  • 1 - 5

Datasets